<!– –> <!– Page Last Updated: 05/29/2014 –> Page Last Updated: 05/29/2014 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Safe Use Initiative
<!– –> <!– Page Last Updated: 05/20/2014 –> Page Last Updated: 05/20/2014 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Current Projects
Acetaminophen Atypical antipsychotic medication use in pediatric populations Colchicine Compounded oral liquid medicationsEpidural steroid injectionsIsotretinoinMedication adherenceNonsteroidal anti-inflammatory drugs for the treatment of pain in geriatric patients Opioid misuse and abuseOpioid patient-prescriber agreementPreventing surgical firesSafe injection practicesUnintentional medication overdoses in children Acetaminophen Improving prescription container labels for acetaminophen-containing medicines Acetaminophen, used for treating pain and fever,…
Comunicado de la FDA sobre la seguridad de los medicamentos: Estudio de la FDA de pacientes de Medicare encontró menor riesgo de derrame cerebral y muerte con Pradaxa (dabigatrán) en comparación con warfarina
<!– –> <!– Page Last Updated: 05/16/2014 –> Page Last Updated: 05/16/2014 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose
<!– –> <!– Page Last Updated: 05/15/2014 –> Page Last Updated: 05/15/2014 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
FDA study of Medicare patients finds risks lower for stroke and death but higher for gastrointestinal bleeding with Pradaxa (dabigatran) compared to warfarin
<!– –> <!– Page Last Updated: 05/13/2014 –> Page Last Updated: 05/13/2014 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
FDA permits manufacturers of oral health care benzocaine products to include a methemoglobinemia warning
<!– –> <!– Page Last Updated: 05/12/2014 –> Page Last Updated: 05/12/2014 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
FDA Provides Facts About Zohydro
<!– –> <!– Page Last Updated: 04/30/2014 –> Page Last Updated: 04/30/2014 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
FDA requires label changes to warn of rare but serious neurologic problems after epidural corticosteroid injections for pain
<!– –> <!– Page Last Updated: 04/23/2014 –> Page Last Updated: 04/23/2014 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
September 20, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement
Agenda The committee will discuss new drug application (NDA) 22–512, dabigatran etexilate mesylate capsules, sponsored by Boehringer Ingelheim Pharmaceuticals, Inc., for the proposed indication of prevention of stroke in patients with atrial fibrillation (abnormally rapid contractions of the atria, the upper chambers of the heart). Meeting Materials FDA intends to make background material available to…